The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Lactate Dehydrogenase

Lactate Dehydrogenase

Lactate dehydrogenase (LDH) is an enzyme found in nearly all living cells.
It catalyzes the interconversion of pyruvate and lactate with concommitant interconversion of NADH and NAD+.
LDH is a useful biomarker for a variety of conditions, including tissue damage, cancer, and metabolic disorders.
Accurate and reproducible LDH analysis is critical for clinical applications and research.
PubCompare.ai's AI-driven protocols can help optimize your LDH research by quickly identifying the most effective products and procedures from the literature, preprints, and patents.
Take the guessweork out of your LDH studies with PubCompare.ai.

Most cited protocols related to «Lactate Dehydrogenase»

We obtained the medical records and compiled data for hospitalized patients and outpatients with laboratory-confirmed Covid-19, as reported to the National Health Commission between December 11, 2019, and January 29, 2020; the data cutoff for the study was January 31, 2020. Covid-19 was diagnosed on the basis of the WHO interim guidance.14 A confirmed case of Covid-19 was defined as a positive result on high-throughput sequencing or real-time reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay of nasal and pharyngeal swab specimens.1 (link) Only laboratory-confirmed cases were included in the analysis.
We obtained data regarding cases outside Hubei province from the National Health Commission. Because of the high workload of clinicians, three outside experts from Guangzhou performed raw data extraction at Wuhan Jinyintan Hospital, where many of the patients with Covid-19 in Wuhan were being treated.
We extracted the recent exposure history, clinical symptoms or signs, and laboratory findings on admission from electronic medical records. Radiologic assessments included chest radiography or computed tomography (CT), and all laboratory testing was performed according to the clinical care needs of the patient. We determined the presence of a radiologic abnormality on the basis of the documentation or description in medical charts; if imaging scans were available, they were reviewed by attending physicians in respiratory medicine who extracted the data. Major disagreement between two reviewers was resolved by consultation with a third reviewer. Laboratory assessments consisted of a complete blood count, blood chemical analysis, coagulation testing, assessment of liver and renal function, and measures of electrolytes, C-reactive protein, procalcitonin, lactate dehydrogenase, and creatine kinase. We defined the degree of severity of Covid-19 (severe vs. nonsevere) at the time of admission using the American Thoracic Society guidelines for community-acquired pneumonia.15 (link)All medical records were copied and sent to the data-processing center in Guangzhou, under the coordination of the National Health Commission. A team of experienced respiratory clinicians reviewed and abstracted the data. Data were entered into a computerized database and cross-checked. If the core data were missing, requests for clarification were sent to the coordinators, who subsequently contacted the attending clinicians.
Publication 2020
Biological Assay Blood Chemical Analysis Complete Blood Count COVID 19 C Reactive Protein Creatine Kinase Electrolytes Kidney Lactate Dehydrogenase Liver Nose Outpatients Patients Pharynx Physicians Pneumonia Procalcitonin Radiography, Thoracic Radionuclide Imaging Real-Time Polymerase Chain Reaction Respiratory Rate Reverse Transcriptase Polymerase Chain Reaction RNA-Directed DNA Polymerase X-Ray Computed Tomography

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adenovirus Infections Adrenal Cortex Hormones Antibiotics Bacteria Biological Assay Blood Bronchi Bronchoalveolar Lavage Fluid Complete Blood Count COVID 19 Creatine Kinase Electrolytes Feces Genes, env Influenza Influenza in Birds isolation Kidney Lactate Dehydrogenase Liver Mechanical Ventilation Methylprednisolone Middle East Respiratory Syndrome Coronavirus Nasal Cannula Nose Oligonucleotide Primers Oseltamivir Oxygen Parainfluenza Pathogenicity Patients Pharynx Physical Examination Physicians Pneumonia Real-Time Polymerase Chain Reaction Respiratory Rate Respiratory Syncytial Virus Respiratory System SARS-CoV-2 Serum Severe acute respiratory syndrome-related coronavirus Sputum Tests, Blood Coagulation Tests, Diagnostic Therapeutics Treatment Protocols Virus Virus Release

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adult BLOOD Cardiovascular Diseases COVID 19 Creatine Kinase Critical Illness D-Alanine Transaminase Emergencies Ferritin fibrin fragment D Heart Heart Disease, Coronary Hypersensitivity Inpatient Lactate Dehydrogenase Lymphocyte Count Lymphopenia Middle East Respiratory Syndrome Patients Serum Severe Acute Respiratory Syndrome Survivors Troponin I

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Blood Chest Chinese Complete Blood Count Cough COVID 19 Creatine Kinase Dyspnea Electrolytes Enzymes Ferritin Fever Inpatient Interleukin-6 Kidney Lactate Dehydrogenase Liver Lung Myocardium Patient Discharge Pharynx Physical Examination Physicians Procalcitonin Radiography, Thoracic Real-Time Polymerase Chain Reaction Respiratory Rate SARS-CoV-2 Serum Signs and Symptoms, Respiratory Tests, Blood Coagulation X-Ray Computed Tomography

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
Animals Bacteria Biological Assay Cytokine Flow Cytometry Immunofluorescence Immunofluorescence Microscopy Lactate Dehydrogenase Light Microscopy Macrophage Microarray Analysis Microscopy Mus Real-Time Polymerase Chain Reaction RNA, Small Interfering Sequence Analysis, Protein Transmission Electron Microscopy

Most recents protocols related to «Lactate Dehydrogenase»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
BLOOD Chest Congenital Abnormality COVID 19 C Reactive Protein Diverticulitis Extracorporeal Membrane Oxygenation Ferritin fibrin fragment D Intestines Lactate Dehydrogenase Lung Lymphocyte Noninvasive Ventilation Oxygen Oxygen Saturation Patients Training Programs
Buffy coats, the fraction of an anti-coagulated blood sample that contains most of the white blood cells and platelets after the centrifugation of the blood (500 mL blood in 70 mL citrate phosphate dextrose coagulant), from five healthy human (consensual) blood donors, were obtained from Sanquin Blood Supply in Rotterdam, the Netherlands. PBMCs were isolated from each buffy coat within 24 h after blood collection, aliquoted, and cryopreserved. PBMCs were stimulated for 48 h with QR-1011 candidates AON32, AON44, AON59, or AON60 at a concentration of 1 μM and 10 μM; positive control R848 (1 μM); or PBS (vehicle control) at 37°C under a 5% CO2 atmosphere. For every donor, all conditions were tested in triplicate in 96-well round-bottom microtiter plates. The total number of viable PBMCs per well was 3 × 105. R848 (Resiquimod [tlrl-r848]; InvivoGen, San Diego, CA, USA), a potent Toll-like receptor (TLR)7/8 agonist, was selected as a positive control for its strong and robust immune-activating properties, inducing the production of pro-inflammatory cytokines. Also, R848 acts on the TLRs that are most likely to be involved in recognition of single-strand RNA, arguably making it the most relevant positive control for this purpose. After incubation, cell culture supernatant was isolated following centrifugation (300 relative centrifugal force for 5 min at room temperature). The viability of PBMCs after exposure to test items was assessed by resazurin reduction assay (CellTiter-Blue Reagent; Promega, Madison, WI, USA). Cytotoxicity was assessed by measurement of lactate dehydrogenase in the cell culture supernatant (CyQUANT LDH Cytotoxicity Assay; Thermo Fisher Scientific). Readout of viability and cytotoxicity assays was performed on a SpectraMax M5 Microplate reader. Cytokine levels in PBMC culture supernatants were measured using the MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel-Custom 6 Plex-Immunology Multiplex Assay (Merck KGaA, Darmstadt, Germany). Analytes included IFN-α2, IL-6, IP-10, MIP-1α, MIP-1β, and tumor necrosis factor-α. Assay plates were read on the Luminex MAGPIX platform (Luminex, San Francisco, CA, USA). Analysis of the Luminex data was performed in Bio-Plex Manager 6.1 software (Bio-Rad). Standard curves were fitted using five-parameter logistic regression. Cytokine concentrations that were outside of the detectable range of the assay were imputed for the purpose of calculation and statistical analysis. Values below the limit of detection (LOD), rendered “out of range <” by the analysis software, were imputed with a concentration value of ½ × LOD. The LOD values, which were empirically determined by the manufacturer of the Luminex kit, were derived from the technical data sheet. Conversely, cytokine concentrations that were above the upper limit of quantification, rendered “out of range >” by the analysis software, were imputed with a concentration value of two times the concentration of the highest calibrator.
Full text: Click here
Publication 2023
Atmosphere Biological Assay BLOOD Blood Platelets Cell Culture Techniques Centrifugation Chemokine citrate phosphate dextrose Coagulants Cytokine Cytotoxin Donor, Blood Homo sapiens Inflammation Lactate Dehydrogenase Leukocytes Promega resazurin resiquimod SERPINA3 protein, human Tissue Donors TLR8 protein, human Tumor Necrosis Factor-alpha
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the Mexican Social Security Institute (protocol 2021–1909-106, August 9, 2021). This is a retrospective and non-interventional study, where medical records were consulted and data in the public repository are de-identified.
This study was carried out with records from patients hospitalized in the Zone General Hospital No. 4 “Villa Guadalupe” located in Guadalupe, Nuevo Leon, Mexico. Patients 60 of years old and older with confirmed COVID-19 diagnosis by RT-PCR test and hospitalized between December 1, 2020 and January 5, 2021 were included. A database was collected that included social security number, age, comorbidities, days of hospitalization, outcome, and date of discharge or death. Database, raw and processed are available at Mendeley Data, V1, https://doi.org/10.17632/z4z22nbmmz.1. ABC-GOALScl, which incorporates clinical and laboratory results, was used and scored as previously described [13 (link)]. This model includes sex, systolic arterial pressure (SAP), presence or absence of dyspnea by respiratory frequency (RF), Charlson comorbidity index, glucose serum levels, obesity, albumin serum levels, lactate dehydrogenase (LDH) serum levels, and SpFi coefficient (Saturation of oxygen/fraction of inspired oxygen, SO2/FiO2, ratio). Subjects who had incomplete clinical records, were diagnosed with Acinetobacter spp. infection or Clostridium difficile, had records that came from another unit, or were directly admitted to the ICU were excluded. Files from subjects who voluntarily requested to leave the study were deleted.
The distribution of continuous variables was evaluated with Kolmogorov–Smirnov. Descriptive statistics were used to analyze the data; qualitative variables are described in frequencies and percentages. For comparison of qualitative variables, chi-squares and stepwise multivariate logistic ordinal regression models were run to calculate adjusted odds ratio (OR) and 95% Confidence Interval (CI) for each component of the ABC-GOALScl score. For quantitative data, a t–test and a Mann–Whitney U test were performed. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the curve (AUC) were calculated, and a value of p < 0.05 was considered significant.
Full text: Click here
Publication 2023
Acinetobacter Infections Clostridium difficile COVID 19 Dyspnea Ethics Committees, Research Glucose Hospitalization Hypersensitivity Lactate Dehydrogenase Obesity Oxygen Saturation Patient Discharge Patients Respiratory Rate Reverse Transcriptase Polymerase Chain Reaction Serum Serum Albumin Systolic Pressure
IMR-32 cells were treated with BMAA in a range of different dosages (0, 0.8, 1.6, 3.2, 6.4, 12.8, 25 uM) and incubated under normal growth conditions over a period of 72 hours. U118-MG cells were treated with BMAA in a range of different dosages (0, 1, 5, 25 uM) and incubated under normal growth conditions over a period of 24 hours or seven days. To detect cell lysis, the presence of extracellular lactate dehydrogenase (LDH) was assessed in cell media at 24, 48, and 72 hours using the CyQUANT LDH Cytotoxicity Assay Kit (Invitrogen, Waltham, MA) according to the manufacturer’s instructions. Cell lysis was quantified using a Molecular Devices SpectraMax Microplate Spectrophotometer (San Jose, CA).
Full text: Click here
Publication 2023
Biological Assay Cells Cytotoxin Lactate Dehydrogenase Medical Devices Menstruation Disturbances
Cell viability was assessed by quantifying lactate dehydrogenase (LDH) released into the culture media upon plasma membrane disruption. The assay was performed using the CyQUANT LDH Cytotoxicity Assay Kit (ThermoFisher, C20301) following the manufacturer’s instructions. In some cases, cell death was also evaluated by trypan blue exclusion staining.
Full text: Click here
Publication 2023
Biological Assay Cell Death Cell Survival Culture Media Cytotoxin Lactate Dehydrogenase Plasma Membrane Trypan Blue

Top products related to «Lactate Dehydrogenase»

Sourced in United States, United Kingdom, Germany, France, Switzerland, Japan, Spain, Italy, China
The CytoTox 96 Non-Radioactive Cytotoxicity Assay is a colorimetric assay that quantitatively measures lactate dehydrogenase (LDH), a stable cytosolic enzyme released upon cell lysis. The assay provides a simple and rapid method for determining cytotoxicity.
Sourced in Germany, Switzerland, United States, United Kingdom, France, Canada, China, Spain
The Cytotoxicity Detection Kit is a laboratory equipment product designed to assess cell viability and cytotoxicity. It provides a quantitative measurement of cell death or cell lysis resulting from cytotoxic compounds, cell-mediated cytotoxicity, or other cytotoxic events.
Sourced in United States, United Kingdom, France, Italy, Switzerland
The CytoTox 96 Non-Radioactive Cytotoxicity Assay kit is a colorimetric assay designed to quantify cytotoxicity by measuring the release of lactate dehydrogenase (LDH) from damaged cells. The assay provides a simple, reproducible method for determining cytotoxicity in a variety of cell types.
Sourced in United States, United Kingdom, Germany, Belgium, France
The Pierce LDH Cytotoxicity Assay Kit is a colorimetric assay that quantifies lactate dehydrogenase (LDH) activity released from damaged cells. The kit provides reagents to measure LDH levels, which is an indicator of cell cytotoxicity or cell lysis.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in China, United States
The LDH Cytotoxicity Assay Kit is a laboratory reagent used to measure the activity of the enzyme lactate dehydrogenase (LDH) released from damaged cells. This assay provides a quantitative measure of cytotoxicity or cell death.
Sourced in Germany, Switzerland, United States, United Kingdom, France, Italy, Canada, Japan, Poland
The Cytotoxicity Detection Kit (LDH) is a laboratory equipment product manufactured by Roche. The kit measures the activity of lactate dehydrogenase (LDH), an enzyme released from damaged cells, to detect and quantify cell death or lysis.
Sourced in Japan, United States, France, China
The LDH Cytotoxicity Detection Kit is a laboratory equipment product that measures the activity of lactate dehydrogenase (LDH) enzyme released from damaged cells. This assay provides a quantitative method to determine cytotoxicity or cell death.
Sourced in United States, United Kingdom, Germany, France, Japan
The CytoTox 96 is a colorimetric assay for the quantitative measurement of lactate dehydrogenase (LDH) released upon cell lysis. It provides a simple and reliable method for determining the cytotoxic potential of various compounds or treatments.
Sourced in United States, Canada, Germany
Lactate dehydrogenase is an enzyme that catalyzes the interconversion of lactate and pyruvate. It is commonly used in clinical laboratories for the analysis of various biological samples.

More about "Lactate Dehydrogenase"

Lactate dehydrogenase (LDH) is a ubiquitous enzyme found in nearly all living cells.
It plays a crucial role in the interconversion of pyruvate and lactate, as well as the interconversion of NADH and NAD+.
LDH is widely recognized as a valuable biomarker for a variety of clinical conditions, including tissue damage, cancer, and metabolic disorders.
Accurate and reproducible LDH analysis is critical for both clinical applications and research.
Optimizing LDH research can be a complex process, but PubCompare.ai's AI-driven protocols can help streamline the process.
By quickly identifying the most effective products and procedures from the literature, preprints, and patents, PubCompare.ai can take the guesswork out of your LDH studies.
This is especially useful when working with related assays, such as the CytoTox 96 Non-Radioactive Cytotoxicity Assay, Cytotoxicity Detection Kit, CytoTox 96 Non-Radioactive Cytotoxicity Assay kit, Pierce LDH Cytotoxicity Assay Kit, and the LDH Cytotoxicity Assay Kit.
When conducting LDH research, it's important to consider factors such as fetal bovine serum (FBS) and its potential impact on LDH levels.
The Cytotoxicity Detection Kit (LDH) and LDH Cytotoxicity Detection Kit can provide valuable insights into measuring LDH activity and cell viability.
Additionally, the CytoTox 96 assay can be used to assess cytotoxicity and cell death, further enhancing your understanding of LDH's role in various biological processes.
By leveraging PubCompare.ai's AI-powered comparisons and insights, researchers can identify the most effective LDH protocols, products, and procedures, ensuring their studies are as reproducible and informative as possible.
Take the guesswork out of your LDH research and maximize the impact of your findings with the help of PubCompare.ai.